SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-009477
Filing Date
2021-07-28
Accepted
2021-07-28 16:15:50
Documents
14
Period of Report
2021-07-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmc-20210728x8k.htm   iXBRL 8-K 41858
2 EX-10.1 bpmc-20210728xex10d1.htm EX-10.1 1400741
3 EX-10.2 bpmc-20210728xex10d2.htm EX-10.2 23627
  Complete submission text file 0001558370-21-009477.txt   1749929

Data Files

Seq Description Document Type Size
4 EX-101.SCH bpmc-20210728.xsd EX-101.SCH 3184
5 EX-101.LAB bpmc-20210728_lab.xml EX-101.LAB 15246
6 EX-101.PRE bpmc-20210728_pre.xml EX-101.PRE 9845
7 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20210728x8k_htm.xml XML 4673
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 211122714
SIC: 2834 Pharmaceutical Preparations